Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effect of Cysteine on Transforming Growth Factor Β1 As the Main Cause of Renal Disorder in a Rat Model of Diabetic Nephropathy



Mahdavifard S1 ; Nakhjavani M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Biochemistry, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
  2. 2. Department of Endocrinology and Metabolism, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Mazandaran University of Medical Sciences Published:2019

Abstract

Background and purpose: Glycation products, oxidative stress, and inflammation contribute to the development of diabetic nephropathy (DN) due to the elevation of transforming growth factor-β1 (TGF-β1). This study aimed at investigating the effect of Cysteine (Cys) on TGF-β in DN rat model. Materials and methods: In this experimental study, 40 male Wistar rats were randomly divided into four groups (n=10 per group): control, Cys, DN, and DN + Cys. DN was induced in rats by nephrectomy of the left kidney and injection of streptozotocin. The Cys and DN groups were treated with Cys (0.05% in dirking water) for three months. Glucose, insulin, diverse glycation products, lipid profile, oxidative stress markers, TNF-α, proteinuria, and serum creatinine levels were determined in all rats. Data analysis was done in SPSS V16. Results: Cys decreased the sera level of TGF-β1, renal dysfunction parameters, diverse Glycation, oxidative stress, and inflammatory markers in DN rats. Furthermore, the treatment improved glycemia and dyslipidemia (P> 0.001). Conclusion: Cysteine with antioxidant, anti-glycating, and anti-inflammatory properties ameliorated DN owing to advantageous effects on glucose and lipid metabolism in rats with diabetic nephropathy. Furthermore, this treatment showed multiple protective effects on kidney by reducing the TGF-β1 levels. © 2019, Mazandaran University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Effect of Linalool on the Activity of Glyoxalase-I and Diverse Glycation Products in Rats With Type 2 Diabetes, Journal of Mazandaran University of Medical Sciences (2020)
2. Protective Effect of Acetylcysteine, Histidine, and Their Combination Against Diabetes Vascular Complications in Type-2 Diabetic Rats Via Reducing Nf-Kβ Pathway Signaling, Journal of Diabetes and Metabolic Disorders (2022)
3. Effect of Glutamine on Oxidative Stress, Inflammatory, and Glycation Markers, and the Activity of Glyoxalase System in Diabetic Rats With Atherosclerosis, Journal of Mazandaran University of Medical Sciences (2019)
4. 1,8 Cineole Protects Type 2 Diabetic Rats Against Diabetic Nephropathy Via Inducing the Activity of Glyoxalase-I and Lowering the Level of Transforming Growth Factor-1Β, Journal of Diabetes and Metabolic Disorders (2022)
5. The Synergistic Effect of Antiglycating Agents (Mb-92) on Inhibition of Protein Glycation, Misfolding and Diabetic Complications in Diabetic-Atherosclerotic Rat, European Journal of Medicinal Chemistry (2016)
6. Thiamine Pyrophosphate Improved Vascular Complications of Diabetes in Rats With Type 2 Diabetes by Reducing Glycation, Oxidative Stress, and Inflammation Markers, Medical Journal of the Islamic Republic of Iran (2020)
7. Supplementation With Cysteine Improved Metabolic Syndrome in Rats by Increasing Antioxidant Potential in the Liver and Adipose Tissue, As Well As Decreasing Hepatic Nf-Κb Expression, Food Bioscience (2024)
8. Effect of Pyridoxal Phosphate on Atherosclerosis and Nephropathy Progression in Atherosclerotic Rats, Journal of Advances in Medical and Biomedical Research (2021)
Other Related Docs
9. L-Lysine Supplementation Improved Glycemic Control, Decreased Protein Glycation, and Insulin Resistance in Type 2 Diabetic Patients, International Journal of Diabetes in Developing Countries (2021)